# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Joshua Spector upgrades Eastman Chemical (NYSE:EMN) from Neutral to Buy and raises the price target from $106 to...
Barclays analyst Michael Leithead maintains Eastman Chemical (NYSE:EMN) with a Equal-Weight and raises the price target from...
Collaboration between industry leaders showcases value of a new sustainable innovation.
RBC Capital analyst Arun Viswanathan maintains Eastman Chemical (NYSE:EMN) with a Sector Perform and raises the price target...
Piper Sandler analyst Charles Neivert maintains Eastman Chemical (NYSE:EMN) with a Neutral and raises the price target from ...
Jefferies analyst Laurence Alexander upgrades Eastman Chemical (NYSE:EMN) from Hold to Buy and raises the price target from ...